Results 171 to 180 of about 532,354 (260)

A Systematic Review of Renal Pathology in Chronic Kidney Disease of Uncertain Etiology. [PDF]

Kidney Int Rep, 2021
Gunawardena S, Dayaratne M, Wijesinghe H, Wijewickrama E.   +3 more
europepmc   +1 more source

Decoding the Cardiac Immune Microenvironment and Fibroblast Crosstalk in Radiotherapy Combined with Immunotherapy‐Induced Cardiac Fibrosis Based on Single‐Cell Transcriptomic Analysis

Advanced Science, EarlyView.
This study highlights that radioimmunotherapy drives crosstalk between fibroblasts and immune cells (especially macrophages) in the cardiac microenvironment, with IL‐6 as the key mediator, and tocilizumab alleviates cardiac fibrosis by targeting this interplay.
Yuxi Luo, Ying Yu, Zhimin Zeng, Yanxin Chen, Yali Yi, Zhiqin Lu, Fujuan Zeng, Peng Xu, Daya Luo, Leifeng Chen, Anwen Liu   +10 more
wiley   +1 more source

What's new in medical renal pathology 2025: Updates on podocytopathy and immunofluorescence staining in medical kidney. [PDF]

J Pathol Transl Med
Weins A, Batal I, Romagnani P, Singh G, Raj R, Andeen N, Zuckerman J, Uzzo M, Alexander MP, Satoskar A.   +9 more
europepmc   +1 more source

Iron Metabolism: An Under Investigated Driver of Renal Pathology in Lupus Nephritis. [PDF]

Front Med (Lausanne), 2021
Wlazlo E, Mehrad B, Morel L, Scindia Y.
europepmc   +1 more source

Dual‐Responsive Dynamic Covalent Bond‐Based Assembly of Lipid‐Nanozyme Systems via Multi‐Target Synergy and Efficient Target Enrichment for Ischemic Stroke Therapy

Advanced Science, EarlyView.
This system adopts a biomimetic phospholipid structure, covalently binding iNOS inhibitors, neuroprotective agent PCA and vitamin E derivatives through pH/ROS dual‐responsive bonds, and assembles them with Prussian blue nanozyme to form PBB@AHA. It can efficiently penetrate the blood‐brain barrier and simultaneously release multiple active components ...
Mengcheng Guo, Qingran Guan, Guanyu Qiao, Lixue Zhang, Man Liu, Zhen Li, Qingbiao Yang, Meili Shen, Linlin Liu, Yapeng Li   +9 more
wiley   +1 more source

The predictive value of suPAR for glomerular segmental sclerosis lesions in renal pathology. [PDF]

Ren Fail
Zhang Z, Liu C, Han Y, Li D, Huang Y, Shi K, Xia S, Wei J, Liu H, Sun L, Zhu X, Yuan S.   +11 more
europepmc   +1 more source

Urinary galectin-3 binding protein (G3BP) as a biomarker for disease activity and renal pathology characteristics in lupus nephritis. [PDF]

Arthritis Res Ther, 2022
Ding H, Shen Y, Lin C, Qin L, He S, Dai M, Okitsu SL, DeMartino JA, Guo Q, Shen N.   +9 more
europepmc   +1 more source

Combating VEGFA‐siRNA‐Induced Metabolic Reprogramming via Glucose Utilization Deprivation

Advanced Science, EarlyView.
An ionizable lipid nanoparticle co‐delivers VEGFA siRNA and glucose oxidase to tumors to counteract VEGFA knockdown‐induced, glutamine‐driven metabolic compensation. Enzymatic glucose consumption reverses the adaptive pathways and restores metabolism toward baseline, thereby sensitizing tumors to therapy.
Lulu Zheng, Shuai Guo, Yingjixing Luo, Pengfei Wu, Haiyin Yang, Yingqiu Xie, Yuchuan Fan, Qing Liu, Bo Hu, Jia Huang, Yuanyu Huang   +10 more
wiley   +1 more source

In Silico Multi-Compartment Detection Based on Multiplex Immunohistochemical Staining in Renal Pathology. [PDF]

Proc SPIE Int Soc Opt Eng, 2021
Jen KY, Murali LK, Lutnick B, Ginley B, Govind D, Mori H, Gao G, Sarder P.   +7 more
europepmc   +1 more source

Doppler ultrasound as a screen for hepatic artery thrombosis after liver transplantation. [PDF]

, 1986
Bowen, A, Bron, KM, Penkrot, RJ, Segel, MC, Skolnick, ML, Slasky, BS, Starzl, TE, Zajko, AB   +7 more
core   +1 more source